The Other Stem Cell Debate
By Jamie Shreeve,
The New York Times
| 04. 10. 2005
Except for the three million human brain cells injected into his
cranium, XO47 is just an average green vervet monkey. He weighs about
12 pounds and measures 34 inches from the tip of his tail to the
sutured incision on the top of his head. His fur is a melange of black,
yellow and olive, with white underparts and a coal-black face. Until
his operation, two days before I met him, he was skittering about an
open-air enclosure on the grounds of a biomedical facility on the
Caribbean island of St. Kitts. Afterward, he was caged in a hut shared
with half a dozen other experimental monkeys, all of whom bore
identical incisions in their scalps. Judging from the results of
previous experiments, the human neural stem cells inserted into their
brains would soon take hold and begin to grow, their fibers reaching
out to shake hands with their monkey counterparts. The green vervets'
behavior was, and will remain, all monkey. To a vervet, eye contact
signals aggression, and when I peered into X047's cage, he took
umbrage, vigorously bobbing...
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...